Do you want to read an article? Please log in or register.
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Thrombosis and Stroke
Related content
Cardiovascular Risk and Diseases
Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study
ESC Heart Fail
Fayol A, Livrozet M, Boutouyrie P, Khettab H, Betton M, Tea V, Blanchard A, Bruno RM, Hulot JS, French COVID cohort study group.
doi: 10.1002/ehf2.13315
Cardiac Arrest or Death
In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study
BMJ
Hayek SS, Brenner SK, Azam TU, Shadid HR, Anderson E, Berlin H, Pan M, Meloche C, Feroz R, O'Hayer P, Kaakati R, Bitar A, Padalia K, Perry D, Blakely P, Gupta S, Shaefi S, Srivastava A, Charytan DM, Bansal A, Mallappallil M, Melamed ML, Shehata AM, Sunderram J, Mathews KS, Sutherland AK, Nallamothu BK, Leaf DE, STOP-COVID Investigators., STOP-COVID Investigators.
doi: 10.1136/bmj.m3513
Further Publications
Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries
Eur Heart J
CAPACITY-COVID Collaborative Consortium and LEOSS Study Group .
doi: 10.1093/eurheartj/ehab656
Cardiovascular Risk and Diseases
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
JAMA Cardiol.
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C
doi: 10.1001/jamacardio.2020.0950.
Thrombosis and Stroke
Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome
Circulation.
Zhang L, Feng X, Zhang D, Jiang C, Mei H, Wang J, Zhang C, Li H, Xia X, Kong S, Liao J, Jia H, Pang X, Song Y, Tian Y, Wang B, Wu C, Yuan H, Zhang Y, Li Y, Sun W, Zhang Y, Zhu S, Wang S, Xie Y, Ge S, Zhang L, Hu Y, Xie M
doi: 10.1161/CIRCULATIONAHA.120.046702.
RECOMMENDED
Hypertension
Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Hypertension
Semenzato L, Botton J, Drouin J, Baricault B, Vabre C, Cuenot F, Penso L, Herlemont P, Sbidian E, Weill A, Dray-Spira R, Zureik M
doi: 10.1161/HYPERTENSIONAHA.120.16314
Further Publications
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
JAMA Cardiol.
Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, Gold HS
doi: 10.1001/jamacardio.
Cardiovascular Risk and Diseases
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy
Eur Heart J.
Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, Italia L, Zaccone G, Tedino C, Fabbricatore D, Curnis A, Faggiano P, Gorga E, Lombardi CM, Milesi G, Vizzardi E, Volpini M, Nodari S, Specchia C, Maroldi R, Bezzi M, Metra M
doi: 10.1093/eurheartj/ehaa388.
Cardiac Arrest or Death
Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study
Lancet Public Health.
Marijon E, Karam N, Jost D, Perrot D, Frattini B, Derkenne C, Sharifzadehgan A, Waldmann V, Beganton F, Narayanan K, Lafont A, Bougouin W, Jouven X
doi: 10.